(AsiaGameHub) - Fincore and Sportradar have revealed a strategic partnership to integrate Fincore's TRI platform with Sportradar's VAIX personalization AI suite. The collaboration is intended to enable betting and gaming operators to leverage AI-powered insights instantly within their current platforms. According to the companies, the TRI ecosystem is built to connect with existing player account management (PAM), gaming, and bonus systems without the need for a complete platform overhaul. It is also designed to meet the audit and access-control standards of regulated markets. Sportradar stated that its VAIX suite offers AI models that generate personalized recommendations and predictive player insights for both sports and casino verticals. These insights include forecasts for customer lifetime value, churn probability, likelihood to deposit, and ideal bonus offers. The company noted that VAIX functions in real time, analyzing player activity to deliver relevant recommendations and rewards during active gameplay. Mateja Popovic, CEO at Fincore, said: “The technology landscape in gaming is evolving and operators are increasingly seeking to embed best-of-breed innovation directly into their core operations. “Our partnership allows Sportradar customers to act on powerful AI-driven insights instantly, closing the gap between prediction and execution. By enabling personalised and automated recommendations and rewards without disrupting existing platforms, we are helping operators unlock greater engagement and more efficient promotional strategies that help them stand out.” Andreas Hartmann, VP Personalisation at Sportradar, said: “Our AI platform gives operators a decisive edge in player engagement and retention, delivering highly accurate predictions on player activity, lifetime value, churn risk, deposit behaviour and more per user, in real-time. “With Fincore’s TRI platform supporting real-time and deep personalisation, integration was a natural fit, allowing us to turn our industry-leading AI models into measurable commercial impact for the operator, across the user journey.” This article is provided by a third-party. AsiaGameHub (https://asiagamehub.com/) makes no warranties regarding its content. AsiaGameHub delivers targeted distribution for iGaming, Casino, and eSports, connecting 3,000+ premium Asian media outlets and 80,000+ specialized influencers across ASEAN.
Mitsubishi Motors’ Outlander PHEV Ranks No. 1 in Japan’s PHEV Sales Category for the Second Consecutive Year
Outlander PHEVTOKYO, Apr 15, 2026 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Motors Corporation (hereafter, Mitsubishi Motors) announced that the plug-in hybrid electric vehicle (PHEV) model of the Outlander crossover SUV (Outlander PHEV), achieved No. 1 in domestic sales in Japan’s PHEV category in fiscal year 2025(1), with sales totaling 7,794 units, marking its second consecutive year at the top(2).Since 1964, Mitsubishi Motors has contributed to the advancement of electrification through research and development of electrified vehicles. In 2009, Mitsubishi Motors launched the i-MiEV, the world’s first mass-produced electric vehicle, followed by the introduction of the Outlander PHEV in 2013 as the world’s first plug-in hybrid electric SUV. The company further expanded its electrified vehicle lineup in 2020 with the addition of the Eclipse Cross PHEV, steadily advancing its electrification strategy.The Outlander PHEV has earned high acclaim in major markets including Japan, North America, Europe, and Australia, and has grown into a leading model in the electrified SUV segment. In March 2025, cumulative sales for the Outlander PHEV surpassed 100,000 units in the Japanese market. In Canada, the model ranked No. 1 in the PHEV category for three consecutive years, achieving a high market share across multiple key markets.Mitsubishi Motors has been promoting the deployment of electrified vehicles based on the view that battery electric vehicles (BEVs) are well suited for kei-cars(3) and compact cars typically used within a relatively limited range of daily activity, while PHEVs are optimal for SUVs and mid-size and larger vehicles used for broader driving needs. Going forward, Mitsubishi Motors will continue to pursue a pragmatic approach to electrification tailored to regional characteristics and usage environments by offering a diverse lineup of electrified vehicles centered on PHEVs, combined with BEVs and hybrid electric vehicles (HEVs).Outlander PHEV(4)As Mitsubishi Motors’ flagship model, the Outlander PHEV is designed to serve as an EV for daily use and a hybrid for longer trips. The electrified SUV delivers quiet, smooth yet powerful acceleration unique to electrified vehicles, along with safe and secure rides in various weather and road conditions.The current, second-generation Outlander PHEV was fully redesigned in 2021, bringing together the best of the brand's electrification and all-wheel control technologies. Developed under the product concept “I-Fu-Do-Do,” a Japanese expression meaning authentic and majestic, the model evolved significantly in both performance and presence.In October 2024, Mitsubishi Motors launched an updated model featuring a newly enhanced drive battery that extended EV range and improved acceleration performance. The update also enhanced the quality of interior and exterior design, expanded advanced features, and adopted an audio system developed in collaboration with Yamaha Corporation as standard equipment on all grades, further strengthening the vehicle’s overall product appeal.Fiscal 2025 is from April 2025 to March 2025.According to Japan Automobile Dealers Association (JADA) ratingsKei-car is a vehicle category in Japan for microcars. Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
OBI Pharma Announces Ten Poster Presentations at the AACR 2026 Annual Meeting for GlycOBI(R) Glycan-based Site-Specific Antibody-Drug Conjugates (ADCs): Mono and Bi-Specific (inc. Dual payload) and Obrion(TM) ADC enabling technologies
TAIPEI, TW, Apr 15, 2026 - (ACN Newswire via SeaPRwire.com) - OBI Pharma, Inc. (TPEx:4174.TWO) today announced its presence at AACR 2026, highlighted by ten poster presentations, showcasing the transformative potential of the GlycOBI® platform. Conventional ADCs often face limitations due to random conjugation, resulting in heterogeneous Drug-to-Antibody Ratios (DAR), suboptimal stability, and narrow therapeutic windows. In contrast, the OBI site-specific glycan-based technology enables a highly homogeneous DAR, translating into improved PK/PD profiles, and reduced off-target toxicity, as demonstrated by OBI's lead programs, OBI-902 and OBI-904.We are further advancing precision oncology through our next-generation bispecific (OBI-201) and bispecific, dual-payload (OBI-221) ADCs. These "biology - driven" molecules are designed to overcome tumor heterogeneity and multi-drug resistance-key challenges in current cancer treatment. By incorporating both the GlycOBI® and GlycOBI DUO® platforms, OBI is developing novel and differentiated therapeutics addressing the unmet medical need for patients with difficult-to-treat solid tumors. Additionally, OBI's robust ADC conjugation platform has proven to consistently deliver product quality and scalability, while enabling expansion into next-generation modalities, including degrader-antibody conjugates (DACs).These data will be presented at the American Association of Cancer Research (AACR) Annual Meeting from April 17 to 22, 2026 in San Diego, CA. (USA)."At OBI, we make better ADCs," said Dr. Ya-Chi Chen, Chief Scientific Officer OBI Pharma. "Our goal is to deliver therapies that not only target tumors more effectively and precisely, but also reduce side effects, giving patients potentially life-changing treatment options."Monday, April 20, 2026 (9:00 AM - 12:00 PM)Title: Overcoming Resistance with OBI-902: Preclinical Evaluation of a Next-Generation TROP2 ADC1Authors: Ren-Yu Hsu, Chi-Huan Lu, Chi-Sheng Shia, Jing-Rong Huang, Hsin-Shan Wu, Lu-Tzu Chen, Jhih-Jie Yang, Tzu-Min Yen, Jyy-Shiuan Tu, Yu-Hsuan Tsao, Ya-Chi Chen. OBI Pharma, Inc, Taipei, TaiwanSession Title: PO. ET07.01 - Quantitative Pharmacology and Translational ModelingLocation: Poster Section 17Poster Board Number: 6Abstract Presentation Number: 1818Title: OBI-904, a Next-Generation Nectin-4-Targeting Exatecan ADC, Demonstrates Enhanced Cytotoxicity and Overcomes Enfortumab Vedotin Resistance2Authors :Yuan-Liang Wang, Chi-Huan Lu, Woan-Eng Chan, Shin-Jin Lin, Ting-Yu Chang, Hong-Syuan Lin, Wei-Jhen Huang, Ya-Chi Chen. OBI Pharma, Inc, Taipei, TaiwanSession Title: PO.ET02.02 - Antibody-Drug Conjugates and Linker Engineering 2Location: Poster Section 13Poster Board Number: 26Abstract Presentation Number: 1729Title: OBI-904, a Glycan-based Site specific Nectin-4-Targeted ADC, Demonstrates Potent and Durable Antitumor Activity with an Improved PK Profile and Overcoming EV-Resistance in Non-Clinical Studies3Authors: Chi-Huan Lu, Ren-Yu Hsu, Jing-Jie Ciou, Tzu Min Yen, Jyy-Shiuan Tu, Yu-Hsuan Tsao, Jing-Rong Huang, Ya-Chi Chen. OBI Pharma, Inc., Taipei, TaiwanSession Title: PO.ET07.01 - Quantitative Pharmacology and Translational ModelingLocation: Poster Section 17Poster Board Number: 7Abstract Presentation Number: 1819Title: The MET/HER3 Antibody-Drug Conjugate with Dual Payload: A Dual-Target Approach to Eliminate Tumor Escape Mechanisms5Authors: Yuan-Liang Wang, Chi-Huan Lu, Woan-Eng Chan, Ting-Yu Chang, Hong-Syuan Lin, Cheng-Yen Wei, Shin-Jin Lin, Lu-Tzu Lu, Meng-Hsin Liu, Wei-Jhen Huang, Ya-Chi Chen. OBI Pharma, Inc., Taipei, TaiwanSession Title: PO.CL.0705 - Targeted Antigen Therapies and ImmunityLocation: Poster Section 49Poster Board Number: 17Abstract Presentation Number: 2665Title: Guide-effector bsADCs: Driving co-endocytosis for enhanced payload delivery6Authors: Wei-Jhen Huang, Woan Eng Chan, Meng-Hsin Liu, Yueh Chin Wu, Ya-Chi Chen .OBI Pharma, Inc., Taipei, TaiwanSession Title: PO.ET02.02 - Antibody-Drug Conjugates and Linker Engineering 2Location: Poster Section 13Poster Board Number : 27Abstract Presentation Number: 1730Title: Hydrophilicity-Enhanced Linker Technology Enables Site-Specific Degrader-Antibody Conjugates with Improved Stability and Enhanced Activity7Authors: Yu-Hung Chen, Wei-Chien Tang, Chi-Dian Lu, Hung-Yi Lin, Wei-Jhen Huang, Nan-Hsuan Wang, Ya-Chi Chen, Teng-Yi Huang. OBI Pharma, Inc., Taipei, TaiwanSession Title: PO.ET02.02 - Antibody-Drug Conjugates and Linker Engineering 2Location: Poster Section 13Poster Board Number: 28Abstract Presentation Number: 1731Title: Cell-based payload release highlights design, site, and cell-dependent ratio shifts in dual-payload ADCs8Authors: Nan-Hsuan Wang, Wei-Han Lee, Evelyn He, Li Chuan Huang, Yu-Chao Huang, David Teng-Yi Huang, Ya-Chi Chen. OBI Pharma, Inc, Taipei, TaiwanSession Title: PO.CH01.06 - Antibodies, Antibody-Drug Conjugates, and Nucleic AcidsLocation: Poster Section 38Poster Board Number: 5Abstract Presentation Number: 2397Monday, April 20, 2026 (2:00 PM - 5:00 PM)Title:TROP2 Upregulation and Interaction with HER2 Mediate Trastuzumab Resistance4Authors: Yuan-Liang Wang, Chi-Huan Lu, Cheng-Yen Wei, Jye-Yu Huang, Woan-Eng Chan, Lu-Tzu Chen, Ya-Chi Chen. OBI Pharma, Inc., Taipei, TaiwanSession Title: PO.ET03.06 Drug Resistance 1: Antibodies and ADCsLocation: Poster Section 12Poster Board Number: 18Abstract Presentation Number: 2972Tuesday, April 21, 2026 (9:00 AM - 12:00 PM)Title: Glycan-based site specific ADC Achieves Sustained Tumor Control through Improved Payload Delivery and Immune Activation9Authors: Liu Chih-Chun, Tsai Yi-Chien, Huang Jing-Rong, Lo Fei-Yun, Pei Yu, Hsu Ren-Yu, Tu Tzu-Hsuan, Chen Ya-Chi. OBI Pharma, Inc, Taipei, TaiwanSession Title: PO.IM02.04 - Adaptive Immunity in CancerLocation: Poster Section 6Poster Board Number: 2Abstract Presentation Number: 4234Title: Advancing ADC therapeutics with next-generation site-specific glycan conjugation and dual-payload flexibility10Authors: Wei-Chien Tang, Yu-Hung Chen, Chih-Kang Chang, Ting-Wei Liu, Hung-Yi Lin, Wei-Jhen Huang, Chi-Huan Lu, Ren-Yu Hsu, Nan-Hsuan Wang, Ya-Chi Chen,Teng-Yi Huang. OBI Pharma, Inc, Taipei, TaiwanSession Title: PO.ET02.03 - Antibody-Drug Conjugates and Linker Engineering 3Location: Poster Section 12Poster Board Number: 1Abstract Presentation Number: 4423The e-posters will be available for browsing at the AACR virtual meeting platform beginning at 12:00 PM PT on April 17, as well as on the OBI Pharma website (www.obipharma.com) beginning on April 18.1 AACR Annual Meeting 2026 Abstracts online https://www.abstractsonline.com/pp8/#!/21436/presentation/45832 AACR Annual Meeting 2026 Abstracts online https://www.abstractsonline.com/pp8/#!/21436/presentation/53853 AACR Annual Meeting 2026 Abstracts online https://www.abstractsonline.com/pp8/#!/21436/presentation/45884 AACR Annual Meeting 2026 Abstracts online https://www.abstractsonline.com/pp8/#!/21436/presentation/50305 AACR Annual Meeting 2026 Abstracts online https://www.abstractsonline.com/pp8/#!/21436/presentation/40516 AACR Annual Meeting 2026 Abstracts online https://www.abstractsonline.com/pp8/#!/21436/presentation/54007 AACR Annual Meeting 2026 Abstracts online https://www.abstractsonline.com/pp8/#!/21436/presentation/54018 AACR Annual Meeting 2026 Abstracts online https://www.abstractsonline.com/pp8/#!/21436/presentation/64749 AACR Annual Meeting 2026 Abstracts online https://www.abstractsonline.com/pp8/#!/21436/presentation/131110 AACR Annual Meeting 2026 Abstracts online https://www.abstractsonline.com/pp8/#!/21436/presentation/5403About OBI PharmaOBI Pharma is a clinical-stage global oncology company established in 2002 and headquartered in Taiwan. Together with its subsidiary OBI Pharma USA, Inc., the company is dedicated to developing innovative cancer therapeutics to provide new treatment options for patients with urgent medical needs.OBI's research efforts center on novel antibody-drug conjugates (ADC). Through its patented next-generation conjugation technology platform, Obrion™, OBI has established diverse ADC design modalities. The platform integrates proprietary conjugation and linker technologies, including GlycOBI®, GlycOBI DUO®, EndoSymeOBI®, HYPrOBI®, and the novel irreversible cysteine-conjugation technology ThiOBI® , to advance next-generation ADC solutions. OBI has developed a next-generation suite of ADC programs. These include monospecific ADCs such as OBI-902 (TROP2), which is under Ph1 clinical evaluation, and OBI-904 (Nectin-4); a bispecific single-payload ADC, OBI-201 (HER2 x TROP2); and a bispecific dual-payload ADC, OBI-221 (cMET x HER3). To broaden the applicability of the HYPrOBI® linker technology, OBI has further developed the ThiOBI® technology to enable irreversible cysteine-based conjugation. In addition to its ADC programs, OBI's assets include OBI-3424, a first-in-class AKR1C3-targeted small-molecule prodrug that selectively releases a potent DNA-alkylating agent in the presence of the aldo-keto reductase 1C3 enzyme, which is highly expressed in certain tumors. Additional information can be found at www.obipharma.com.About OBI-902 and OBI-992OBI-902 is a TROP2-targeted antibody-drug conjugate (ADC) that carries a potent topoisomerase I inhibitor payload to kill tumor cells with a drug-antibody ratio (DAR) of 4. TROP2 is highly expressed in a variety of solid tumors such as breast, lung, biliary, bile duct (cholangiocarcinoma), ovarian, gastric, and many other cancer types, rendering it an ideal target for cancer therapy.OBI-902 is a novel site-specific glycan-conjugated ADC using OBI's proprietary GlycOBI® platform, which provides improved stability and enhanced hydrophilicity. OBI-902 demonstrated remarkable antitumor efficacy across multiple tumors, including NSCLC, triple-negative breast cancer (TNBC), and gastric cancer, improved pharmacokinetic characteristics, and a favorable safety profile in various animal models. The IND of OBI-902 was cleared by the United States Food and Drug Administration (US FDA) on April 30, 2025, received Orphan Drug Designation (ODD) from the US FDA for cholangiocarcinoma on Nov. 16, 2025, and gastric cancer (GC), including gastroesophageal junction cancer (GEJC) on December 5, 2025.The Phase 1/2 Study (NCT07124117) is ongoing, with completion of the Phase 1a portion targeted for 1H 2027.OBI-992 is a TROP2-targeted antibody-drug conjugate (ADC) that carries a potent topoisomerase I inhibitor payload with drug-to-antibody ratio of 4 (DAR 4) via a cysteine conjugated, hydrophilic and enzyme-cleavable linker. OBI-992 remains stable in circulation and delivers this cytotoxic payload to TROP2-expressing tumor cells, leading to tumor cell death while avoiding off-target toxicities.The US FDA cleared the IND application for OBI-992 in Jan 2024 and subsequently granted Orphan Drug Designation for the treatment of gastric cancer, including GEJC in Aug 2024. The Phase 1/2 Study (NCT06480240) has reached the putative Recommended Phase 2 Dose (pRP2D) and Phase I completion is targeted for 1H 2027.Since December 2021, OBI has been granted by Biosion, Inc. (www.biosion.com) an exclusive license to a TROP2 targeting antibody amino acid sequence in all jurisdictions except Mainland China, Hong Kong and Macau. Biosion holds exclusive rights to that antibody sequence in Mainland China, Hong Kong and Macau. OBI holds commercial rights to OBI-992 and OBI-902 in all jurisdictions except Mainland China, Hong Kong and Macau, while Biosion holds commercial rights to OBI-992 and OBI-902 in Mainland China, Hong Kong and Macau.About OBI-904OBI-904 is an antibody-drug conjugate (ADC) comprised of a monoclonal antibody specifically targeting Nectin-4 (Nectin cell adhesion molecule 4), linked to a potent topoisomerase I inhibitor payload with Drug-to-Antibody Ratio of 8 (DAR8) through OBI's proprietary GlycOBI® ADC enabling technologies, powered by a dual-function enzyme, EndoSymeOBI®, and a novel linker, HYPrOBI®. It is a potentially first-in-class and best-in-class glycan-based ADC designed to target multiple cancer types that express Nectin-4. Antitumor activity has been shown across several animal disease models, including HNSCC, CRC, TNBC, cervical and sarcoma cancers; OBI-904 has demonstrated a favorable safety profile in a repeat dose toxicity study in monkeys, and is now in the pre-IND stage of development.About OBI-201OBI-201 is a TROP2 x HER2 bispecific ADC generated by OBI GlycOBI® ADC enabling technologies conjugated with a topoisomerase I inhibitor. Notably, OBI is the first to demonstrate that HER2 and TROP2 can interact and form a protein complex on the cell surface-a groundbreaking discovery facilitated through collaboration with a specialized AI drug discovery partner. OBI-201 offers several advantages over mono-specific TROP2 or HER2 ADCs. By targeting both antigens, it broadens tumor coverage, especially in cancers with heterogeneous or low expression of either target. Dual targeting can enhance tumor selectivity, binding avidity, and internalization, improving payload delivery to cancer cells while potentially reducing toxicity to normal cells. OBI-201 may overcome resistance associated with downregulation of targets after treatment by certain monospecific ADCs.Animal studies revealed that OBI-201 demonstrated significantly superior anti-tumor activity compared to single-target ADCs in drug-resistant breast cancer models with extremely low HER2 expression. OBI-201 was able to sustain tumor growth suppression, indicating its potential to overcome multiple drug-resistance mechanisms. OBI-201 is a next-generation bispecific ADC poised to break through the limitations of single-target ADCs, potentially offering patients a more comprehensive and durable treatment option.About OBI-221OBI-221 is a Bispecific-Dual Payload ADC (BsDpADC), generated by OBI GlycOBI DUO® technologies, targeting cMET and HER3, conjugated with dual payload of MMAE and topoisomerase I inhibitor.In clinical practice, EGFR-targeted therapies have become a key strategy for treating non-small cell lung cancer (NSCLC) and colorectal cancer (CRC) patients. However, tumors often rapidly develop resistance by upregulating cMET and HER3 that, in turn, sustain tumor growth. Moreover, high expressions of cMET and HER3 have been observed in gastric cancer, head and neck cancer, and various other solid tumors, further underscoring the unmet medical needs.To address this challenge, OBI Pharma leverages its proprietary GlycOBI DUO® platform and HYPrOBI® linker to develop a novel bispecific dual-payload antibody-drug conjugate (BsDpADC)-OBI-221. This therapeutic agent simultaneously targets cMET and HER3 while delivering synergistic cytotoxic agents, effectively combating tumor resistance and heterogeneity. This breakthrough design not only addresses an unmet medical need but also represents a forward-looking strategy for next-generation ADC development.OBI-221 holds meaningful potential to overcome resistance to existing EGFR-targeted therapies, potentially offering patients more targeted treatment options while delivering substantial clinical value.About GlycOBI®OBI has developed a unique glycan-based, site-specific ADC technology (GlycOBI®), designed in a Plug and Play format that is compatible with any antibodies, linkers, and payloads, and supports various drug-antibody ratios (DAR)(up to 16). Powered by OBI's proprietary dual-function enzymatic technology EndoSymeOBI® and its hydrophilic linker technology HYPrOBI®, GlycOBI®, a core component of OBI's Obrion™ ADC technology family, enables the generation of site-specific and homogeneous ADCs through an efficient, scalable and streamlined two-step, one-pot conjugation process under GMP conditions.During the conjugation process, GlycOBI® avoids disrupting the antibody structure and ensures that the resulting ADC retains biophysical characteristics comparable to the native antibody. In addition, OBI's linker technology improves payload conjugation efficiency and reduces the propensity for aggregation or degradation, further supporting a stable and well-controlled ADC manufacturing process. GlycOBI® has overcome limitations commonly associated with traditional ADC approaches and has demonstrated improved antitumor activity and stability in various in vivo studies. Notably, the platform supports the conjugation of both cytotoxic small-molecule inhibitors and highly hydrophobic degraders, expanding its applicability to next-generation modalities such as DACs.About GlycOBI DUO®GlycOBI DUO® is a next-generation dual-payload antibody-drug conjugate (ADC) technology built on the GlycOBI® site-specific conjugation platform and its proprietary enzymatic conjugation strategy. It enables the precise and programmable attachment of two distinct payloads to a single antibody with tunable ratios and supports high DAR ratios, including up to DAR24. By combining complementary mechanisms of action, GlycOBI DUO® is designed to enhance antitumor efficacy, address tumor heterogeneity, and improve the overall therapeutic index, with the potential to overcome resistance mechanisms associated with conventional ADCs-representing a promising advancement in next-generation ADC development.About ThiOBI®OBI has developed a novel irreversible, cysteine conjugation ADC platform (ThiOBI®) with improved stability, which can apply to any antibodies, linkers, and payloads. OBI's proprietary ThiOBI® platform including linker technologies (HYPrOBI®) can generate ADCs in different biomolecular formats, including antibody fragments, nanobodies, peptides, and proteins. Furthermore, OBI's HYPrOBI® linker technology has improved conjugation efficiency of the payload and reduced aggregation propensity and also expanded the half-life of the ADC products. ThiOBI has overcome the limitations of traditional cysteine ADCs and achieved better antitumor activity and stability in various in vivo tests.GlycOBI®, EndoSymeOBI®, ThiOBI®, HYPrOBI®, and GlycOBI DUO® are registered trademarks of OBI. Obrion™ is a trademark under registration.Forward-Looking StatementsStatements included in this press release that are not a description of historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements about future clinical trials, results and the timing of such trials and results. Such risk factors are identified and discussed from time to time in OBI Pharma's reports and presentations, including OBI Pharma's filings with the Taiwan Securities and Futures Bureau.COMPANY CONTACT:Jukka MuhonenExecutive Director, Business DevelopmentOBI Pharma USA, Inc.1.617.821.0292jukkamuhonen@obipharma.comSOURCE: OBI Pharma USA, Inc. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
LuckyCasino Starts Operations in Spain
(AsiaGameHub) - LCKY Group announced that LuckyCasino has officially gone live in Spain. As a brand within the LCKY Group portfolio, this online casino marks the company's second venture in the Spanish market, following OneCasino. LCKY Group noted that LuckyCasino is expanding upon its existing experience in Sweden. According to LCKY Group, the Spanish launch will feature over 2,000 games, featuring numerous titles exclusive to LuckyCasino, as well as tailored promotions and payment solutions. Mark Schram, MD B2C Central & South Europe at LCKY Group, commented: “The entire team at LuckyCasino is eager to demonstrate the blend of variety and innovation that has made our platform a massive success in other regions. “Spain represents a crucial market for our future growth, and we are thrilled to expand upon the success LCKY Group has already achieved there with OneCasino. We anticipate that our extensive content library will be highly attractive to Spanish players.” This article is provided by a third-party. AsiaGameHub (https://asiagamehub.com/) makes no warranties regarding its content. AsiaGameHub delivers targeted distribution for iGaming, Casino, and eSports, connecting 3,000+ premium Asian media outlets and 80,000+ specialized influencers across ASEAN.
Red Papaya Sets Forth with Pirate’s Fight for Fortune
(AsiaGameHub) - The studio, powered by Microgaming, hoists the sails for big wins with a nautical adventure that boasts a colossal 20,000x maximum payout. In its newest slot, Pirate’s Fight for Fortune, Red Papaya calls on players to board a formidable pirate vessel and embark on a journey over dangerous waters in pursuit of vast riches. Taking place during the Golden Age of Piracy, the game provides an exhilarating seafaring experience with intrepid pirate captains, shrewd navigators, and famous maritime scoundrels, all in a quest for wealth and fame. This medium-volatility game strikes a balance between regular action and enormous winning possibilities, capped by an astonishing Grand Jackpot worth 20,000 times the stake. While the adventure progresses on a ship scarred by battle, players will encounter cursed treasures, magical keys, and old maps seized from enemy vessels. To discover the most valuable rewards, players need to conquer the open ocean by mastering a set of innovative features built for optimal player retention: Multi-Tiered Bonus System: A distinctive triggering mechanism that provides three separate engagement tiers: Bronze, Silver, and Gold Bonuses. The Collect Mechanic: Pirate Coins that land on reels 1 through 4 are collected immediately if a Collect symbol appears on reel 5, generating moments of high excitement in the base game. Multiplier Potential: More than just an activator, the Collect symbol also bears a Multiplier from 1x to 5x, which is applied to the combined value of all Coins gathered in that spin. The Boost Feature: An extra strategic option for players, which raises the total bet by 50% to boost the appearance rate of Silver and Gold Pirate Coins and substantially raise the odds of activating bonus rounds. Here is a closer look at the bonus gameplay. The core of the experience is its ongoing collection system and "Hold & Win" type bonus rounds, which include: Persistent Collection – Any Pirate Coin that lands is added to color-coded treasure chests displayed above the reels, offering a visual indicator of progress and an opportunity to activate the corresponding bonus. Dynamic Bonus Symbols – Special symbols enhance the action during bonus rounds, like the Captain Multiplier (which increases the total Multiplier) and the First Mate Extra Spin (which adds to the spin reset count), fostering excitement for extended play sessions. Three-Tiered Jackpots – Within the bonus game, players can pursue three fixed jackpots: Mini: 10x Major: 50x Grand: 20,000x Created for a worldwide player base, Pirate’s Fight for Fortune is perfectly optimized for play on both mobile and desktop platforms and has an RTP of 96.37%. Madelein Ozok, Head of Studio at Red Papaya, stated: "For Pirate’s Fight for Fortune, our goal was to merge a timeless high-seas setting with an advanced, multi-layered bonus framework. The game's premium artwork and captivating sound design also contribute to a compelling narrative that we are aware players enjoy. “By implementing a persistent collection feature that increases anticipation with each spin, and providing three different tiers of bonus gameplay coupled with a huge 20,000x Grand Jackpot, we have developed a highly engaging product that distinguishes itself in any operator's portfolio." Technical Specifications: RTP: 96.37% Volatility: Medium Max Win: 20,000x Hit Frequency: 27.19% Layout: 5×4 Reels, 40 Fixed Paylines Bet Range: 0.20 – 12.50 This article is provided by a third-party. AsiaGameHub (https://asiagamehub.com/) makes no warranties regarding its content. AsiaGameHub delivers targeted distribution for iGaming, Casino, and eSports, connecting 3,000+ premium Asian media outlets and 80,000+ specialized influencers across ASEAN.
SpinsFriends Collaborates with NetRefer for Its Affiliate Marketing Platform
(AsiaGameHub) - SpinsFriends, an online casino brand specializing in slots, has entered into a partnership with NetRefer, a leading data-driven, AI-powered affiliate marketing platform. This collaboration will be instrumental in powering and managing SpinsFriends' affiliate program as the brand expands its reach within regulated European markets. SpinsFriends is dedicated to providing a slots-centric gaming experience, emphasizing engaging gameplay and rewarding mechanics. Operated by BALTENT, the brand prioritizes free spins, continuous promotions, and a user-friendly journey, aiming to attract and retain players with a dynamic and accessible offering. The platform boasts a comprehensive selection of slot titles, complemented by classic table games and live casino options. Its two brands, Spins and Aladins, contribute to a varied and captivating gaming environment, ensuring SpinsFriends can cater to diverse player preferences while maintaining a consistent, entertainment-focused experience. Operating within regulated jurisdictions, SpinsFriends adheres to established standards for compliance, transparency, and responsible gaming. These principles are central to the operator's approach, underpinning the standards that guide its ongoing expansion. Affiliate marketing is a crucial component of SpinsFriends' growth strategy. By choosing NetRefer, the operator gains access to a platform designed for clear performance metrics, dependable tracking, and efficient partner management, empowering the team to monitor affiliate activities and optimize program performance. Through NetRefer’s Data Ingestion API, SpinsFriends benefits from a streamlined and structured data transfer process, enabling accurate tracking and real-time insights into affiliate activities. This integration facilitates efficient data management while retaining the flexibility needed to scale operations as the program grows. In addition to these integrations, NetRefer's comprehensive ecosystem offers further capabilities to support the scaling of affiliate program performance. Solutions like NetRefer’s BI Analytics solution and the Report Builder provide advanced, customizable reporting. NetRefer CoPilot AI enhances access to performance insights and operational knowledge through intelligent, data-driven assistance. Enhanced Tracking further improves visibility into traffic quality by combining Bot Detection and User Agent Details for deeper insights into user behavior. Artūrs Sarma, CEO and Founder at BALTENT, stated, “NetRefer already had an existing integration with our platform provider, which made the decision straightforward and allowed us to move quickly with the setup. As we scale, having clear reporting and flexible commission structures is important, and the platform gives us the tools to manage our affiliate programme in a structured and efficient way. The onboarding process was well supported, and the team guided us through each step, which made the overall experience smooth.” Yuliia Borshch, NetRefer’s dedicated Account Manager for SpinsFriends, commented, “SpinsFriends is a brand with a clear focus on building a structured and scalable affiliate programme, and we’re pleased to support that with technology designed to deliver both clarity and flexibility. Our platform provides the tools needed to manage performance with confidence, maintain transparency across its affiliate programme, and adapt as requirements evolve. We look forward to working closely with their team as they continue to grow.” As SpinsFriends continues to expand its presence in regulated markets, the partnership with NetRefer provides the necessary technology and operational foundation to support the growth of its affiliate program. With enhanced performance visibility, scalable infrastructure, and improved insight and reporting capabilities, the operator is well-positioned to strengthen its partner network and achieve sustainable growth. This article is provided by a third-party. AsiaGameHub (https://asiagamehub.com/) makes no warranties regarding its content. AsiaGameHub delivers targeted distribution for iGaming, Casino, and eSports, connecting 3,000+ premium Asian media outlets and 80,000+ specialized influencers across ASEAN.
品創控股深化AI產業佈局 賽博幻境回聲生態戰略全球啟動
香港, 2026年4月15日 - (亞太商訊 via SeaPRwire.com) - 品創控股有限公司（「品創控股」或「公司」，連同其附屬公司統稱為「集團」；股份代號：8066）欣然宣佈，集團全資附屬公司賽博幻境（香港）有限公司（「賽博幻境」）於今日隆重舉行《語音 AI 之 Echo 生態戰略全球啟幕盛典》，正式啟動其全球語音 AI 回聲生態系統（Echo Ecosystem，「回聲生態」）戰略，構建從語音數據採集、處理到商業應用的全鏈路閉環。此舉標誌著集團在人工智能語音數據服務領域的戰略佈局邁入全新階段，為集團深化 AI 業務轉型、打造長效增長曲線奠定堅實基礎。針對語音數據採集規模、質量與多樣性的行業困境，賽博幻境創造性推出區塊鏈遊戲與語音數據採集相結合的全新模式。用戶參與遊戲時，完成指定文本的語音錄製任務，既可享受遊戲樂趣，亦可獲得代幣激勵。該「遊戲化採集」模式，可大規模、高效率獲取覆蓋不同年齡、地域、口音與情感表達的真人語音數據，為構建多元化聲音數據庫提供穩定持續的來源。採集完成後，回聲平台透過專業清洗、標註與分類處理，將原始語音轉化為可直接用於 AI 訓練的結構化聲音數據庫。相關數據庫於 AI 數據市場以回聲代幣交易，供全球開發者及企業採購使用，形成「用戶參與採集 — 獲取代幣激勵 — 數據加工處理 — 市場交易流通 — 產業應用賦能」的完整價值鏈閉環。該模式不僅大幅降低語音 AI 開發門檻，更讓數據貢獻者、開發者及終端用戶共享語音 AI 發展所帶來的裨益。「語音 AI 不僅是技術，更是未來數字世界的入口。」賽博幻境首席執行官郭曉鵬先生在盛典上表示，「回聲生態致力於構建語音 AI 時代的基礎設施，透過去中心化的數據採集網絡和開放的聲音數據庫市場，我們將為全球 AI 開發者提供最豐富、最優質的聲音數據資源，推動語音 AI 技術在各行各業的快速落地和應用創新。」當前，人工智能技術加速滲透各行各業，人機對話已成為 AI 應用場景的核心交互方式。語音 AI 技術作為 AI 智能體不可或缺的組成部分，正成為連接人類與數字世界的入口。高品質、多元化的聲音數據庫是 AI 智能體強化訓練的核心基礎，語音 AI 技術發展已進入「數據驅動」新階段，優質聲音數據庫不僅可顯著提升語音合成的情感表現力、語音識別的場景適應性與對話系統的個性化能力，更成為語音 AI 產業發展的核心競爭力與先發優勢所在。品創控股銳意推動業務多元化佈局，把握數字經濟與人工智能產業的蓬勃商機，並憑藉前瞻性轉型，成功構建「私域電商營運 + AI 技術服務」雙輪驅動的業務架構。本次回聲生態全球啟動，是集團深化 AI 業務佈局、推動主營業務向 AI 數據服務轉型的關鍵里程碑。展望未來，集團將以賽博幻境為核心載體，持續深耕語音 AI 技術研發，拓展生態合作網絡，推動技術在智能客服、數字人、元宇宙、智能汽車等前沿領域深度融合；同時深化兩大業務協同效應，強化核心競爭力，推動業務高質量發展，把握全球 AI 產業廣闊機遇，致力為股東創造可持續長期回報。圖片說明 賽博幻境首席執行官郭曉鵬先生講解去中心化語音網絡的價值實現，彰顯品創控股推動語音 AI 技術在各行各業的快速落地和應用創新的決心。關於品創控股有限公司品創控股有限公司的使命是妥善運用公司所獲得的資本與獨特投資機會，為股東提供穩定的優渥收入與獲利。品創控股由六個主要事業部門組成，包括智能卡製造服務、電子商務、人工智能、投資服務、資源回收投資與媒體與娛樂投資，主要業務為生產及銷售智能卡、提供定製智能卡應用系統、私域電子商務平台營運、人工智能語音技術數據服務、提供財務及管理諮詢服務、廢舊金屬銷售及貿易、以及媒體與娛樂行業之投資。公司的總部位於香港，旗下控股公司與投資則遍佈大中華地區。關於賽博幻境（香港）有限公司賽博幻境（香港）有限公司是品創控股有限公司的全資子公司，專注於語音人工智能技術的研發與應用。賽博幻境致力於通過創新的生態模式，打造從數據采集、處理到商業落地的全鏈條語音AI解決方案，助力全球智能語音產業的發展。 Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
營收1648.9億創新高 MSCI ESG評級AAA 賽力斯彰顯豪華新能源車企硬核實力
香港, 2026年4月15日 - (亞太商訊 via SeaPRwire.com) - 近日，中國領先的豪華新能源汽車企業賽力斯（9927.HK）正式發佈2025年度業績報告。報告期內，公司堅守技術創新戰略，持續完善高端產品矩陣佈局，扎實推進可持續發展實踐，深耕豪華新能源汽車賽道，為市場與投資者交出一份亮眼成績單，充分彰顯中國豪華新能源車企強勁的發展韌性與核心競爭優勢。數據顯示，2025年賽力斯實現營業收入約人民幣1648.9億元，同比增長13.63%；歸屬于上市公司股東的淨利潤約人民幣59.6億元，營收規模再創歷史新高，並連續兩年實現盈利，成功達成營收與利潤雙增長、規模與質量雙提升，標誌著公司正式邁入高質量穩健發展新階段，發展根基持續夯實。從營收規模看，賽力斯營收突破1600億元大關，同比保持兩位數增速，顯著領先行業平均水平，展現出強大的市場號召力與品牌影響力；從盈利表現看，公司連續兩年實現盈利，淨利潤穩步增長，盈利能力持續優化，盈利質量顯著提升。技術創新為核，核心競爭優勢持續凸顯雄厚的技術實力，是賽力斯實現穩健增長的核心引擎與立身之本。2025年，公司持續加大研發投入，全年研發費用達125.1億元，同比增長77.4%，研發投入強度與增速均位居行業前列。與此同時，賽力斯堅定推進「增程與純電雙線並行」戰略佈局，報告期內公司增程業務以37.5%的市占率位居中國市場首位；純電車型銷售占比亦持續提升，產品矩陣不斷豐富，全面覆蓋多元細分市場需求，進一步擴大市場領先份額。增程與純電協同發展，既有效破解用戶里程焦慮，精准契合當前新能源汽車消費核心需求，也推動公司技術研發全面升級，助力構建多元化產品優勢，形成差異化競爭格局，持續鞏固在豪華新能源賽道的領先地位，為營收與利潤增長提供堅實支撐。智能輔助駕駛是賽力斯技術創新的另一重要突破口，亦是品牌高端化與智能化實力的關鍵體現。2025年，問界系列累計新增智能輔助駕駛里程38億公里，智能輔助駕駛活躍用戶占比高達95.4%，用戶使用率與信賴度持續攀升；2026年春節期間，問界M9智能輔助駕駛里程占比達51.9%，精准解決長途擁堵疲勞、泊車困難等核心用車痛點。賽力斯在智能輔助駕駛領域的突破，不僅推動產品體驗迭代升級，讓智能科技切實服務於用戶出行，更強化了「軟件定義汽車」的技術標簽，彰顯中國豪華新能源車企在智能化領域的創新實力，為市場拓展與業績增長注入持續動力。ESG賦能高質量發展，堅守可持續發展初心完善的ESG管理體系，是賽力斯實現高質量發展的重要支撐，也是企業踐行社會責任、提升全球競爭力的核心底氣。2025年，賽力斯持續深化ESG治理，將可持續發展理念深度融入生產經營、研發創新、供應鏈管理全流程。與此同時，公司積極推進數字化能源管理系統落地與零碳智慧物流港建設，單車碳排放強度同比下降18.92%；同時聯合供應鏈夥伴發起綠色倡議，開展核心供應鏈碳足跡溯源工作。憑藉扎實的ESG實踐與突出的可持續發展成效，公司獲明晟（MSCI）ESG最高AAA評級，躋身全球新能源車企ESG領先陣營，進一步提升品牌美譽度與行業影響力，為企業長期穩健發展注入持久動能。以技術創新鑄核心競爭力，以ESG實踐賦能長期發展，以優質產品立足高端市場，賽力斯2025年交出一份兼具規模、效益與責任的優異答卷。未來，公司將堅定聚焦高端智能電動汽車主業，不斷加大研發投入，深化增程與純電雙輪驅動佈局，持續深耕豪華新能源賽道，書寫中國高端新能源汽車品牌高質量發展的嶄新篇章。 Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
備受好評的宇宙恐怖遊戲將改編為電影 —— 且帶有令人驚訝的反轉
From Software(SeaPRwire) - 「電玩改編電影魔咒」的日子已經徹底結束了。如今，《超級瑪利歐兄弟電影版》和《我的世界電影版》正在稱霸過往的票房紀錄，而《最後生還者》也成為 HBO 高品質電視陣容的核心之一。既然任何電玩遊戲都有可能被搬上螢幕，那麼接下來會發生什麼就無從得知了——甚至《Weapons》的 Zach Cregger 也正在製作一部《惡靈古堡》電影。 看來下一部大型電玩電影將改編自 2010 年代最受喜愛的電子遊戲之一——但別期待這會是一部《權力的遊戲》風格的奇幻史詩。相反地，這將走一條完全不同的路線。 《血源詛咒》的洛夫克拉夫特式宇宙恐怖將躍升為敘事電影，但會以動畫形式呈現。 | FromSoftware在 CinemaCon 期間，Sony 發布了一部改編自《血源詛咒》的電影，這是 FromSoftware 於 2015 年發行的殘酷且血腥的宇宙恐怖遊戲。根據Variety的報導，Sony Pictures Entertainment Motion Picture Group 總裁 Sanford Panitch 承諾，這部電影將「非常忠實」於《血源詛咒》的血腥精神。為了讓擔心這部電影會由非玩家創作的粉絲放心，Seán McLoughlin（又名 JackSepticEye）被列為製作人。然而，這個即將到來的項目有一個巨大的轉折：這是一部動畫長片。這絕不是一部適合全家觀賞的動畫片——預計將被列為限制級——但它完全不會是真人電影。它不會像 Netflix 的《獵魔人》影集，而會更像 Netflix 的《獵魔人》動畫電影。 《血源詛咒》完美演繹了《黑暗靈魂》的電玩遊戲公式。這將在限制級動畫中呈現出什麼樣的效果？ | FromSoftware這是一個兩極分化的選擇。《血源詛咒》擁有極其細緻的視覺效果，如果這些被簡化為卡通美學，那麼原故事的整個洛夫克拉夫特氛圍就不會被認真對待。然而，如果電影完全是動畫製作，那麼複雜的奇幻戰鬥和魔法元素等特效將會更容易重現，尤其是在預算有限的情況下。 如果有任何工作室能夠公正地製作一部動畫版《血源詛咒》電影，那絕對是 Sony，也就是《蜘蛛宇宙》三部曲背後的工作室。但這是一款邪典經典遊戲，粉絲們投入了數十小時的遊戲時間，對某些粉絲來說，這款遊戲非常個人化。對於這樣高人氣的遊戲和如此冒險的媒介選擇，標準肯定會很高。 這部《血源詛咒》電影尚未有上映日期。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈，覆蓋超過6,500個媒體庫、86,000名編輯和記者，以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
ASEAN Enterprises Move from AI Experiments to Engineering-Driven Deployment
SINGAPORE, Apr 15, 2026 - (ACN Newswire via SeaPRwire.com) - As artificial intelligence adoption accelerates across Southeast Asia, enterprises across the ASEAN region are increasingly establishing structured AI engineering practices to move from experimentation to production-scale deployment.According to Joseph Bosco, Partner Manager, APJ - Prof Services at Databricks, organisations across ASEAN are recognising that sustainable AI adoption depends not only on advanced models but also on robust engineering foundations that ensure reliability, governance and operational scalability.“The early phase of AI adoption focused heavily on experimentation and proofs of concept,” Bosco said. “Across Southeast Asia we are now seeing a shift towards AI engineering practices that prioritise data quality, governance and production readiness.”Markets such as Singapore, Indonesia, Vietnam, Malaysia and Thailand are witnessing strong momentum in enterprise AI adoption as organisations modernise their data infrastructure and invest in advanced analytics capabilities.Industry experts note that AI engineering is becoming a critical discipline that connects AI innovation with enterprise operations. This includes building scalable data pipelines, managing machine learning lifecycle processes and integrating AI systems into business workflows.“Building a model is only one part of the challenge,” Bosco said. “The real work lies in creating reliable data pipelines, managing model lifecycle and embedding AI into operational systems.”Across ASEAN, many enterprises continue to manage complex data environments spanning legacy systems, multiple cloud platforms and software-as-a-service applications. Consolidating these fragmented data sources into unified platforms is increasingly seen as a prerequisite for scaling AI initiatives.Technology partners and consulting firms across the region are responding by developing dedicated AI engineering practices that combine expertise in data engineering, machine learning, generative AI and governance frameworks.These capabilities are already being applied across key sectors including financial services, telecommunications, and manufacturing.Bosco noted that Southeast Asia’s rapidly expanding data economies are creating a particularly dynamic environment for AI engineering talent and innovation.“As organisations across ASEAN continue to invest in data transformation, AI engineering will become an essential capability that enables enterprises to operationalise AI safely and effectively,” he said. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
DCU是否已經找到了新任神奇女侠？
Stephane Cardinale - Corbis/Corbis Entertainment/Getty Images(SeaPRwire) - 啊，新超級英雄電影的熱烈選角。尤其是對於像新DC宇宙這樣新穎、熱門且成敗攸關的事物來說，這種感覺無與倫比。詹姆斯·古恩在《超人》中完成了不可能的任務，選角完美，塑造了一個完美的鋼鐵之軀、一個彷彿出自DC漫畫頁面的露易絲·萊恩，以及一個具有足夠反叛性且真正合適的萊克斯·盧瑟。儘管基礎如此牢固，但他還必須為其即將到來的續集《明日之超人》重新來過……並且在過程中可能會擴建正義聯盟。古恩在為超人傳奇系列的下一部作品集結演員陣容時，全世界的目光都聚焦在他身上。即將上映的電影將是大衛·科倫斯威特的超人和尼古拉斯·霍爾特的萊克斯·盧瑟之間的雙雄對決；這兩股勢力可能會被迫聯手對抗更大的威脅——布萊尼亞克（Lars Eidinger）。他們將加入《超人》的演員陣容，以及亞倫·皮爾斯，他將在HBO的《綠燈俠》中首次亮相約翰·斯圖爾特。如果覺得這個陣容很擁擠，那是因為確實如此，但古恩最近透露，拼圖中還有一塊缺失——而《安多》女星阿德里亞·阿龍索剛剛填補了這一空缺。Arjona is moving from a galaxy far away to the DC Universe. | Lucasfilm阿龍索的名字最近一段時間一直圍繞著新DC宇宙流傳。這位女演員是備受歡迎的神奇女華盛頓幻想選角之一；她曾在2016年的《貝爾科行動》中與古恩合作，這使得重聚的機會大增。但古恩花費了今年大部分時間否認阿龍索會在新DC宇宙中擔任任何角色。即使當《Deadline》透露她正在與《輻射》的艾拉·珀內爾和《業界》的瑪麗莎·阿貝拉一起為《明日之超人》中的一個神秘角色進行試鏡時，這位編劇兼導演也迅速稱這些說法是“胡扯”。當然，如此強烈的反應通常意味著觸動了某根神經。古恩是在信口開河，而且顯然是有充分理由的。儘管《Deadline》暗示阿龍索是扮演馬克西瑪的有力競爭者之一，馬克西瑪是一位對超人有著病態喜愛的外星女戰士女王，但真相可能更為勁爆。《好萊塢報導》的博裡斯·基特和亞倫·考奇今天確認，阿龍索確實贏得了《明日之超人》中的一個角色——但她是否真的在扮演馬克西瑪目前仍“未知”。古恩既沒有確認也沒有否認馬克西瑪會出現在他的即將上映的電影中，所以阿龍索可能扮演任何人（甚至，正如《Inverse》的瑞安·布里特所提出的，像烏爾莎這樣的冷門角色）。既然她*可能*扮演任何人，為什麼不會是神奇女華盛頓呢？Arjona could very well be joining the DCU as Maxima — but it’s not too late to pray for Wonder Woman. | DC Comics說明一下，如果阿龍索後來扮演馬克西瑪，也不會是全無收穫。她有點像超人的“貓女”版本：軍事星球阿爾梅拉克的統治者馬克西瑪被權力所吸引，這使超人成為了她可以共同統治的理想伴侶。值得注意的是，她在1992年的跨界作品《天際恐慌》中與布萊尼亞克聯手，這個情節線索可能是古恩為《明日之超人》汲取的主要靈感來源。這讓她在《明日之超人》中的潛在角色變得更加合理，但馬克西瑪這一角色也可能只是一個誤導。雖然古恩在社交媒體上很健談，但這位電影製片人還是不願意在他準備好之前透露任何東西。他對《明日之超人》的選角過程尤其保密，這可能是因為這部電影隱藏著一個大秘密。畢竟，華納兄弟首席執行官大衛·扎斯拉夫確實聲稱，在《超人》取得成功後，DC工作室將“加速”製作一部神奇女華盛頓電影。即使《明日之超人》是關於超人和萊克斯的故事，也很難不希望看到塞米西拉公主的一瞥。DC推出神奇女華盛頓電影還沒有太久，但《神奇女華盛頓1984》的失望，加上舊DC宇宙的瓦解，呼籲著重建。誰比阿龍索更適合擔當這項任務呢？她在《安多》中低調、堅毅且富有同理心的表演，除了名字外，簡直就像是戴安娜·普林斯的試鏡。在古恩明確確認阿龍索在《明日之超人》中的角色之前，這一切都只是美好的願望。這位女演員可能完全在扮演另一個角色——但如果早期的猜測一直正確，那將會非常令人興奮。Man of Tomorrow flies into theaters on July 9, 2027.本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈，覆蓋超過6,500個媒體庫、86,000名編輯和記者，以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
45年後，最優秀的反烏托邦驚悚片之一將被翻拍
Avco Embassy/Kobal/Shutterstock(SeaPRwire) - 約翰·卡本特是恐怖片界的傳奇人物，但他並非所有電影都是砍殺片，無論背景設定在萬聖節還是北極。他其中最被低估的電影之一就是《紐約大逃亡》，這部由寇特·羅素主演的反烏托邦動作驚悚片有著宏大的概念：在不久的將來，整個曼哈頓島被改造成一個巨大的最高安全級別監獄，這個制度（相對）運作良好，直到空軍一號墜毀，導致總統受困於這個全國公認最危險的地方。這時，蛇眼（羅素 飾）登場了，他獲得了赦免的提議，條件是將總統救出紐約，而這場逃亡行動最終捲入了政治陰謀。將近半個世紀後，這個經典故事即將迎來重大更新。但在向原作致敬的同時，它真的能夠被更新嗎？《紐約大逃亡》是約翰·卡本特電影作品中的重要一環。 | Avco Embassy/Kobal/Shutterstock在CinemaCon期間，StudioCanal宣布正在籌拍《紐約大逃亡》的重啟版，但並未公布任何未來細節。然而，這並非該計畫首次被提及。《紐約大逃亡》的重拍傳言最早可追溯到2007年，當時New Line Cinema購買了版權。多年來，包括導演連恩·威斯曼、布萊特·拉特納、勞勃·羅里葛茲，以及導演雙人組Radio Silence都曾與這個項目有所牽連。傑瑞德·巴特勒最初曾洽談主演，但之後的其他版本都未曾進入選角階段。只是別指望寇特的兒子懷特·羅素會飾演下一代的蛇眼——在2021年接受《Esquire》採訪時，他明確表示在重啟版中飾演蛇眼將是「101種職業自殺行為」，他說。「那就像是『千萬不要做的事』清單上的項目。」懷特·羅素認為沒有人能超越他父親寇特的表演。 | Lee Watt/AFF-USA/Shutterstock但他不僅僅是反對自己接演父親的角色——他認為這個角色根本是無法複製的。「我不知道是否有其他人能成為蛇眼，」他說。「祝你好運，去挑戰吧。我真心祝你好運。我只是不知道這怎麼可能辦到。」而這正是關於這個新項目的終極問題。沒有了約翰·卡本特和寇特·羅素，重拍版真的能成功嗎？還有什麼新東西可說？考慮到原版電影是在水門事件後撰寫的，或許有些政治諷刺可以重新詮釋，但《紐約大逃亡》本身是相當歷久不衰的。也許重拍版會移除一些過時的參考內容，例如懸掛式滑翔機降落在世界貿易中心的情節，但電影的核心與靈魂實在難以被超越。《紐約大逃亡》目前可在Amazon Prime Video上免費串流觀看。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈，覆蓋超過6,500個媒體庫、86,000名編輯和記者，以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
自主研發AI鑒定技術領跑二手市場 中國二手新消費平台「轉轉」進軍香港
香港, 2026年4月15日 - (亞太商訊 via SeaPRwire.com) - 中國領先循環經濟產業新消費公司轉轉集團（下稱：轉轉）近日宣布，其自主研發的AI鑒定產品「AI拍圖驗真」在二手奢侈品鑒定領域取得重大突破，鑒定準確率實現了LV包袋鑒定錯誤率不足萬分之一、GUCCI包袋零錯誤的卓越表現；鑒定效率提升近900倍至「1秒出結果」。集團今年將逐步把AI鑒定拓展至CHANEL、Hermès等熱門品牌，並於未來延伸至腕表等其他二手品類，構建全品類AI鑒定矩陣。憑藉其頂尖AI鑒定能力及創新業務模式的領先優勢，轉轉同步計劃在香港設立國際業務總部，正式開啟全球化佈局。 作為中國頂尖二手交易平台，轉轉自2015年成立以來發展迅速，旗下擁有轉轉、找靚機、紅布林等多個知名二手消費品牌。當前中國二手閑置賽道備受資本與市場矚目，轉轉亦憑藉首創的二手質檢「官方驗」服務脫穎而出。集團已獲包括騰訊、小米、58集團在內的多家知名企業或投資者支持，上一輪融資估值達逾30億美元（約234億港元），去年營收總額突破200億元人民幣，擁有超過4億註冊用戶、5,000萬月活躍用戶。 （圖為北京「超級轉轉」二奢倉店）有別於以Carousell、閑魚等企業為代表的傳統C2C模式，轉轉透過成熟的C2B2C商業模式，以「平台居中、專業鑒定、品質保證」提供差異化平台服務。其首創的「官方驗」服務在對回收商品全方位嚴格檢測後，為其提供一份專屬的質檢報告並公開展示，絕大部分官方驗商品，都可享有7天無理由退貨、一年平台質保、內陸包郵等增值服務。轉轉透過標準化質檢與售後保障，例如履行「驗了再發貨」、「不滿意可退」、「驗錯了就賠」等策略，為消費者提供「所見即所得」的優質體驗。 （圖為轉轉青島智慧質檢中心）技術驅動是轉轉穩居行業領先地位的核心引擎。轉轉去年特別成立了AI事業部，三年內擬投入20億元人民幣研發AI質檢、智能匹配等工具。今年初上線的「AI拍圖驗真」，深度應用於二手奢侈品鑒定領域，系統基於海量真實商品圖片資料庫與深度學習演算法，將傳統需時15分鐘的人工鑒定大幅壓縮至「秒級鑒定」，最快1秒即可出結果，效率提升近900倍；同時在核心包袋品類的鑒定上，更創下錯誤率不足萬分之一的超高準確率（上線至今，LV包袋累計鑒定逾萬單以上，僅錯一單，錯誤率不足萬分之一；GUCCI包袋累計鑒定近3000單，實現零錯誤），徹底打破了傳統非標品交易及人工鑒定中的標準不一、效率樽頸等難題。 轉轉集團創辦人兼行政總裁黃煒表示：「轉轉集團在過去十年間通過持續的技術創新和戰略整合，確立了在中國二手交易市場的領導地位，我們深信領先的技術與質檢能力是打破二手交易壁壘的關鍵。轉轉致力引領中國的二手消費模式，不斷刷新消費者的二手消費體驗，我們對即將在香港設立國際業務總部感到振奮，亦是標誌著轉轉從中國市場邁向國際舞台的重要里程碑。」 （圖為轉轉APP內商品AI鑑定資訊）關於轉轉轉轉集團成立於2015年，是中國領先的循環經濟產業新消費公司，旗下擁有轉轉、找靚機、采貨俠、俠客匯、紅布林等多個二手電商品牌，業務覆蓋手機3C、奢侈品、圖書、潮玩等百餘種餘種品類二手商品交易，在全國佈局超過1,100多家線下門店和超過3,000人的上門回收團隊，通過人工智能質檢技術和創新的C2B2C商業模式，致力解決非標品交易的信任難題，為消費者帶來有「質價比」的二手好物。轉轉作為全國有履約二手商品交易平台的領導企業，去年已錄得超過4億註冊用戶、5000萬月活躍用戶。「技術驅動＋平台服務」為核心引擎，轉轉特設AI事業部，在國立首創二手質檢「官方驗」服務，並先後自主研發AI估價系統、AI拍圖驗真等核心技術產品，打造了二奢行業的頂尖AI鑒定能力，為全球知名熱門的奢侈品牌包袋品類提供秒級且精準的真偽鑒定，持續引領中國二手交易市場向標準化、數字化邁進。傳媒垂詢，請聯絡：轉轉集團公關部 Alan Wei：weixi@zhuanzhuan.com Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
近十年最佳哥吉拉電影導演 將打造全新機甲史詩鉅作
Jeff Kravitz/FilmMagic, Inc/Getty Images(SeaPRwire) - 自《哥吉拉-1.0》（Godzilla: Minus One）2023年風靡全球後，每個人自然都有同樣的問題掛在嘴邊：「山崎貴接下來要做什麼？」這位從視覺特效師轉型的導演證明了他能以小預算辦大事——《Minus One》僅靠1000萬至1500萬美元的預算，就成功復活了這個怪獸IP。大眾無不好奇，若是給他一個符合好萊塢大片等級的預算，他能做出什麼成果，而幸運的是，我們不用等太久就能揭曉答案。山崎不僅將推出《Minus One》的續作，預定2026年後半問世，他同時也埋頭製作自己的英語處女作《Grandgear》。山崎這部新片自2024年就展開籌備。Sony Pictures在激烈競標後拿下了本片的發行權，J.J. Abrams的Bad Robot隨後也加入了製作團隊。當時《Grandgear》的劇情是最高機密——但在今年的Cinemacon上，Sony終於揭露了這部備受矚目電影的劇情，聽起來風格非常接近《Pacific Rim》或是《Neon Genesis Evangelion》。憑藉2023年的《Godzilla: Minus One》獲得一致好評與奧斯卡最佳視覺效果獎後，導演Takashi Yamazaki將目光轉向了機甲題材。| Toho在這場拉斯維加斯的產業大會上，Sony宣布《Grandgear》定檔2028年2月上映，由Yamazaki親自擔任編劇與導演。沒錯，山崎在《Godzilla Minus Zero》之後的下一部作品同樣以怪獸為核心創作方向，這次則是巨型機甲。根據The Playlist說法，Sony在Cinemacon公開的短預告片段中，有一段兩架機甲對戰的畫面，看起來「比Pacific Rim 的世界觀更流暢精致」。目前還不清楚這些機甲是僅互相戰鬥，還是必須聯手對抗同等級的巨型怪獸（部分出自Cinemacon的報導指出，這些機甲要對付的是巨型怪獸），但有山崎掌舵，這部作品肯定會帶來意想不到的翻轉設定。無論如何，自從《Pacific Rim》的續作表現令人失望，導致大眾對巨型機器人的熱潮開始消退後，我們終於有機會看見機甲題材在真人影視獲得應有的發揮了。無論最終劇情為何，能看這位導演如何處理日本流行文化的經典題材都相當令人期待，何況現在還有其他巨型機器人電影即將推出。Netflix正和Legendary合作打造《Gundam》，是一部由Sydney Sweeney主演的真人動作大片。當然，這種題材要容下多部作品絕對不成問題——何況這還是十年來最佳哥吉拉電影導演的新作。《Grandgear》目前仍處製作前期，但這部電影即將到來的事實，就足夠值得慶祝了。Grandgear 將於2028年2月18日在電影院上映。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈，覆蓋超過6,500個媒體庫、86,000名編輯和記者，以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
Exito Media Concepts Announces the 46th Edition of the Digital Transformation Summit Malaysia 2026
KUALA LUMPUR, Malaysia, April 14, 2026 - (ACN Newswire via SeaPRwire.com) - Exito Media Concepts today announced the 46th Edition of the Digital Transformation Summit Malaysia 2026, convening on 23rd April 2026 at the Hyatt Regency Kuala Lumpur Midtown. The summit will bring together more than 200 C-Level executives, technology directors, and government leaders to address the strategic and operational imperatives shaping Malaysia's next phase of digital growth.Now in its 46th edition and part of a series spanning 11+ countries, the summit has established itself as one of Asia Pacific's most consequential forums for enterprise technology leadership.The Strategic Context: Malaysia's Digital Economy at a Critical JunctureMalaysia's digital economy is undergoing a structural shift. Driven by targeted government-led initiatives and accelerating enterprise adoption of artificial intelligence, the Internet of Things, and Web 3.0, organizations across every sector are fundamentally reimagining how they operate, compete, and deliver value.The opportunity is significant. Yet the path to enterprise-wide transformation demands more than technology investment — it requires navigating complex cybersecurity environments, integrating legacy infrastructure with modern digital architecture, developing organizational capabilities at pace, and embedding a culture of innovation that sustains long-term resilience. For Malaysia's business leadership, strategic clarity has never been more consequential.The Digital Transformation Summit Malaysia 2026 is designed precisely for this inflection point.Enterprise Transformation in PracticeThe business case for bold digital action is already being written across Malaysia. A leading domestic enterprise recently undertook a comprehensive digital transformation initiative — transitioning to a cloud-first infrastructure supported by advanced data analytics and AI capabilities.The results were measurable and material: automating key operational processes delivered significant gains in efficiency and organizational agility. The concurrent deployment of robust cybersecurity frameworks ensured data integrity and regulatory compliance. Simultaneously, structured workforce upskilling programmes enabled teams to perform with confidence in an evolving technology environment.The outcome: improved business performance, deeper customer engagement, and a materially stronger competitive position within Malaysia's digital economy. It is precisely this calibre of real-world insight that the Summit is built to surface and scale.Event OverviewThe 46th Edition of the Digital Transformation Summit Malaysia 2026 is part of a globally recognized series of events hosted across 11+ countries. This edition will convene more than 200 C-Level Executives, Directors, Heads of Technology, Government leaders, and digital transformation leaders from across industries.Through expert-led keynotes, panel discussions, and real-world case studies, the summit will highlight innovative strategies, emerging technologies, and actionable insights that empower organizations to drive digital growth and operational excellence.Date: 23rd April 2026Time: 09:00 AM to 05:00 PMVenue: Hyatt Regency Kuala Lumpur MidtownWebsite: https://digitransformationsummit.com/malaysia/Summit Agenda: Technology Priorities Shaping 2026Delivered through expert-led keynotes, high-impact panel discussions, and documented case studies, the Summit agenda will address the technology priorities most consequential to enterprise leaders this year:Artificial Intelligence & Machine Learning Embedding intelligent decision-making and automation across core business functions — from supply chain to customer experience to financial operations.Web 3.0 & Emerging Technologies Navigating decentralized innovation and unlocking new digital ecosystems with long-term enterprise relevance.Internet of Things (IoT) Advancing operational connectivity and efficiency across industries through integrated sensor and data infrastructure.Quantum Computing Examining the practical and strategic implications of the next frontier in computational capability.Cybersecurity & Data Protection Strengthening enterprise digital resilience against an increasingly sophisticated and expansive threat landscape.Cloud & Scalable Infrastructure Building the foundational agility, continuity, and scalability demanded by modern enterprise growth.Digital Culture & Transformation Strategy Developing the leadership frameworks and organizational behaviours that sustain transformation well beyond initial implementation.Data-Driven Decision Making Harnessing analytics to convert raw data into competitive intelligence and measurable business outcomes.About Exito Media ConceptsExito — the word for success — is both the name and the operating philosophy of one of the world's most active B2B events and media organizations. Over 16 years, Exito has built a reputation for delivering 240+ conferences annually across technology, digital transformation, cybersecurity, healthcare, and emerging enterprise sectors worldwide.Every Exito event is defined by meticulous agenda curation, access to world-class speaker communities, and a commitment to market-driven insight that translates directly into strategic value for attendees, sponsors, and partners. The result is a global platform trusted by thousands of senior executives to inform their most consequential decisions.Media ContactPrakruthi NayakaMedia and PR Executive, Exito Media ConceptsEmail: prakruthi.nayaka@exito-e.comWebsite: https://digitransformationsummit.com/malaysia/ Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
以美国调解以色列-黎巴嫩谈判难以解决核心问题 – 学者
(SeaPRwire) - 一位黎巴嫩教授告訴RT，華盛頓無意強迫其盟友結束在黎巴嫩南部的軍事行動 黎巴嫩陸軍軍事學院國際事務與外交學教授Naim Joseph Salem告訴RT，除非華盛頓施壓以色列停止其空襲和地面攻勢，否則美國斡旋的以色列與黎巴嫩直接會談不太可能帶來和平。 以色列和黎巴嫩週二在華盛頓舉行了罕見的談判，但總部設在黎巴嫩的武裝團體Hezbollah抵制了這次談判，稱其「徒勞無功」。 儘管雙方都形容這次會談「具有建設性」，但Salem認為，這種形式很可能導致「遙遙無期且沒有結論」的漫長談判，因為美國無意施壓以色列結束其在黎巴嫩的軍事行動。 在Hezbollah開始向以色列發射火箭彈和迫擊砲以支持伊朗後，Israel Defense Forces (IDF)於三月初恢復了對貝魯特和其他城市的空襲。超過120萬人流離失所，因為以色列在黎巴嫩南部發布了大規模疏散命令，以擴大其「安全區」。 Salem說：「以色列的政策是摧毀整個黎巴嫩南部，以迫使這些城鎮的居民，約45萬人，離開並成為難民」，他補充說，有幾個城鎮已被以色列軍隊「夷為平地」。 本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈，覆蓋超過6,500個媒體庫、86,000名編輯和記者，以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
DENSO Establishes Strategic Partnership with Oracle to Modernize Core Supply Chain Systems
KARIYA, JAPAN, Apr 15, 2026 - (JCN Newswire via SeaPRwire.com) - DENSO CORPORATION (hereinafter “DENSO”) announced today that it has established a strategic partnership with Oracle Corporation (hereinafter “Oracle”) to modernize its core systems in the supply chain domain*1. The two companies began work on this initiative in April.Under the partnership, DENSO will deploy a new global core system based on Oracle Fusion Cloud Applications, incorporating the latest AI technologies. Through this initiative, DENSO aims to build an advanced digital foundation for its supply chain operations.The automotive industry is currently facing increasing complexity in supply chain operations that support manufacturing—including production planning, logistics, and procurement—driven by the advancement of vehicle systems and diversification of vehicles, as well as heightened geopolitical risks. To respond appropriately and swiftly to these changes, it has become increasingly important to strengthen and standardize business processes through the use of digital technologies.DENSO and Oracle have previously worked together to modernize business processes based on cloud technologies in areas such as finance, indirect procurement, and human resources. Building on the knowledge gained through these efforts, the new strategic partnership expands the scope of collaboration to the supply chain domain.Under this partnership, DENSO will combine its extensive expertise in automotive parts manufacturing with Oracle’s latest cloud applications and AI technologies, using Oracle Fusion Cloud Applications as the foundation to globally modernize its core supply chain systems.In addition, DENSO and Oracle will establish an AI Center of Excellence (AI CoE)*2, serving as a central organization to collect knowledge on AI utilization and to promote the full-scale use of advanced AI agents across the initiative.Following a pilot deployment at overseas locations planned for approximately two years from now, the new core system will be rolled out globally in phases. Through the introduction of an AI-driven supply chain core system—a leading initiative within the automotive parts industry—DENSO aims to improve operational efficiency and sophistication while building a resilient, robust, and sustainable supply chain capable of adapting to change.Key Business Transformations Targeted by This InitiativeAdvancement of Business ProcessesData spanning planning, procurement, production, delivery, and accounting across globally dispersed operations will be centrally managed on a cloud-based system, enabling real-time visibility of the entire supply chain. Based on this integrated data foundation, AI will automate routine tasks and provide recommended actions, significantly reducing manual work and enabling employees to focus on higher-value, strategic activities.Accelerated Management Decision-MakingBy leveraging the same data foundation, AI will collect and analyze relevant information and run simulations based on multiple data sets, allowing early identification of procurement and supply risks that previously required manual intervention. This will enable the rapid formulation and evaluation of production, procurement, and supply strategies from a globally optimized perspective, in response to changing environments.Comments from ExecutivesHirotsugu TakeuchiCTO (Chief Technology Officer), CDO (Chief Digital Officer),Head of R&D Center, Head of Production Innovation CenterDENSO CorporationAs supply chain operations continue to grow in complexity, advanced technologies such as AI, together with analytics and forecasting platforms based on integrated data, are no longer optional—they are prerequisites. This initiative goes beyond simple efficiency improvements; it represents a fundamental modernization of our core systems to transform the quality and speed of decision-making on a global scale. By leveraging Oracle Fusion Applications to significantly enhance data accuracy and timeliness, and by embedding AI into day-to-day operations, we will implement a supply chain that is resilient to change.Steve MirandaExecutive Vice President, Applications DevelopmentOracleDENSO’s continued growth and the increased speed and complexity of its supply chain operations required a new AI-centric and integrated approach. With Oracle Fusion Applications, DENSO can adopt an AI-powered system of outcomes that can work across the business to automate end-to-end workflows, boost supply chain performance, and drive efficient global growth.DENSO will continue to partner with other companies to strengthen manufacturing competitiveness and address social challenges, contributing to the realization of a sustainable mobility society.*1 Supply chain domain: Refers to operations related to manufacturing, including procurement, logistics, production, and delivery.*2 AI Center of Excellence (AI CoE): A core organization responsible for consolidating and sharing knowledge and know-how on AI utilization, establishing standards and governance, and providing expert consultation to business units to enable effective and continuous use of AI across the entire core system modernization initiative. Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
Fujitsu and Chugoku Electric Power T&D sign IP licensing agreement to accelerate renewable energy integration and advance power transmission maintenance
KAWASAKI, Japan, Apr 15, 2026 - (JCN Newswire via SeaPRwire.com) - Fujitsu Limited and Chugoku Electric Power Transmission & Distribution Co., Inc. today announced the signing of an intellectual property licensing agreement. This agreement, effective April 15, 2026, covers Chugoku Electric Power T&D's intellectual property, which includes its dynamic line rating technology [1] and intellectual property related to advanced power transmission facility maintenance. The partnership aims to support the expansion of renewable energy adoption and enhance power transmission facility maintenance operations through drone utilization.Under this agreement, Fujitsu will leverage Chugoku Electric Power T&D's intellectual property to launch an advanced power grid operation and maintenance support service for power transmission and distribution companies. This service will enable safe and maximum connection and utilization of renewable energy in the power grid.BackgroundAs the adoption of renewable energy continues to expand, power transmission and distribution companies are working to maximize the use of existing power transmission facilities while maintaining stable operation of the power system [2] . The capacity of transmission lines for safe power transmission varies with environmental conditions like temperature and wind speed. Traditionally, to protect transmission facilities, operations have been based on the transmission capacity under the worst-case conditions. However, dynamic line rating technology, which adjusts transmission capacity based on real-time environmental conditions, is now recognized as a key method for effectively utilizing transmission capacity while making the most of existing facilities.Furthermore, there are concerns that conventional human-dependent maintenance operations, such as inspection and patrolling of power transmission facilities, will face operational challenges in the future due to a shrinking workforce. To address these challenges, initiatives are progressing to utilize digital technologies and drones to efficiently and accurately assess the condition of transmission facilities.Fujitsu has developed technology to acquire and analyze vibration data across all spans of transmission lines using optical fiber sensing technology [3] with a single measuring device, as well as a technology platform for data management and AI analysis. To apply these technologies in a practical operational setting for power transmission and distribution companies, Fujitsu and Chugoku Electric Power T&D have conducted verification tests [4] since September 2021, focusing on expanding renewable energy adoption and enhancing power transmission facility maintenance operations.Service OverviewThe service integrates Chugoku Electric Power T&D's intellectual property, including its dynamic line rating technology and expertise in power transmission facility operation and maintenance, cultivated through verification tests and practical operations, with Fujitsu's optical fiber sensing, data analysis, and AI technologies. It acquires vibration data from optical fibers laid along transmission lines and uses environmental data, such as wind conditions around the transmission lines, derived from this vibration data, to calculate the available transmission capacity according to the real-time facility status. Furthermore, by training and inferring with AI using the acquired data, it becomes possible to predict future wind conditions around transmission lines and transmission capacity. These series of data acquisition, conversion, and prediction functions will be provided as the basic functions of this service.In addition, the data obtained from the basic functions can be utilized to support power transmission and distribution companies in addressing various operational challenges. It supports the operational design and system construction for dynamic line rating technology, thereby reducing renewable energy curtailment and promoting efficient power utilization. Furthermore, wind condition data around transmission lines can guide drone flight feasibility and optimal route selection. By assessing facility conditions from vibration data, the service also facilitates labor-saving and advanced maintenance operations, moving beyond traditional on-site and human-dependent methods.Fujitsu will offer this service to power transmission and distribution companies as part of its "AI Technologies and Solutions" offering under Uvance [5] , a business model focused on addressing societal challenges. Figure: Service Overview Future PlansFujitsu will continue to strengthen this service, including the application of generative AI, to achieve advanced maintenance operations from inspection to repair plan formulation, thereby contributing to the acceleration of digitalization in power infrastructure both domestically and internationally. Furthermore, under Uvance, Fujitsu will advance towards a sustainable and resilient society by enhancing social infrastructure through data and AI.Chugoku Electric Power T&D will continue to advance its technology and accumulate expertise through practical operations, leading the expansion of renewable energy adoption and the sophistication of facility maintenance operations.(1) Dynamic line rating technology:A technology that constantly monitors the status of power transmission lines and adjusts current capacity according to local conditions.(2) Power system:A series of electric power facilities and systems consisting of "transmission," "transformation," and "distribution" to deliver electricity from power stations to customers. (3) Optical fiber sensing technology:A technology that measures in real-time how optical fiber cables are vibrating by inputting specific laser pulses into communication optical fiber cables and measuring changes or components of backscattered light. This measurement uses a dedicated measuring device and a computing system for data processing. (4) Verification tests:Verification tests conducted by Chugoku Electric Power T&D and Fujitsu from September 1, 2021 to September 30, 2022.(5) Uvance:Fujitsu's business model that drives advanced decision-making and business transformation by leveraging data and AI to address societal challenges. It supports both customer business growth and the resolution of societal issues through value co-creation across industries and countries. About FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers around the globe, our 113,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: AI, Computing, Networks, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.6 trillion yen (US$23 billion) for the fiscal year ended March 31, 2025 and remains the top digital services company in Japan by market share. Find out more: global.fujitsuAbout Chugoku Electric Power Transmission & Distribution Co., Inc. Chugoku Electric Power T&D Co., Inc. is a general power transmission and distribution business operator in Japan, located in Naka-ku, Hiroshima City, with five prefectures in the Chugoku region and part of neighboring prefecture as supply areas. A wholly owned subsidiary of Chugoku Electric Power Co., Ltd.https://www.energia.co.jp/nw/index.html (in Japanese)Press ContactsFujitsu LimitedPublic and Investor Relations DivisionInquiries Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
百望股份亮相世界互聯網大會 布局商業信用基礎設施全球化版圖
香港, 2026年4月15日 - (亞太商訊 via SeaPRwire.com) - 4月13-14日，2026年世界互聯網大會亞太峰會在香港會議展覽中心舉辦。百望股份首席戰略官劉揚發表了題為《全球稅務合規：從"財稅數字化"到"中國企業商業信用基礎設施"》的主題演講，深度分享百望股份全球化戰略布局與落地進程，全面展示了百望以AI Agent重構跨境稅務合規體系、搭建中國企業商業信用基礎設施的創新實踐。本次峰會以"數智賦能 創新發展——攜手構建網絡空間命運共同體"為主題，由世界互聯網大會主辦，香港特別行政區政府承辦，香港特別行政區政府創新科技及工業局等協辦。香港特別行政區行政長官李家超出席開幕式並致辭。來自全球50餘個國家和地區的政府部門部長級官員、國際組織高級別代表、駐華使節、互聯網領軍企業代表，以及專家學者等約千名嘉賓參會。百望以商業信用模型架構為核心，築造AI能力壁壘本次世界互聯網大會的亮相，是百望股份上市以來完成AI戰略轉型後，首次在世界級行業論壇的重磅發聲，也是企業全球化戰略的一次全面公開發布。會上，百望股份宣告已完成全球化智能科技公司的全面能力准備，以商業信用模型為核心架構，正式開啟全球化發展新篇章。百望股份是本次大會中唯一一家實現垂直大模型企業級應用落地、且擁有規模化真實商業案例的企業，充分印證了在AI企業級應用賽道的領先身位，全面彰顯了百望股份核心戰略的前瞻性與正確性，驗證了以數據智能為核心、以AI Agent為抓手、以全球化布局為增長曲線的長期戰略布局的精准判斷。基於對AI Agent 時代企業級需求的深度理解，百望股份以動態商業信用模型為核心，完成了產品架構的全面升級，打造了"底層底座-能力中樞-智能執行"的完整閉環產品體系。 百望股份之能成為中國企業商業信用基礎設施的構建者，核心根基就藏在這一架構的底層設計邏輯之中。整個架構以算力平臺為底層支撐，向上搭建了數據中臺、AI中臺、能力中臺三位一體的技術中臺體系。基於交易關系、商品關系、制度關系、金融關系、雇傭關系五大維度，百望股份形成了以百望企信碼為底層底座，以百鏈、百信、百策為數據核心能力中樞，以百望百寶、百望百搭為智能執行應用的群體智能矩陣。區別於傳統財稅軟件的功能疊加模式，百望股份打造的是可生長、可擴展的智能技術底座，這也是商業信用基礎設施能夠持續迭代、適配全球多元場景的核心前提。作為一家善用數據的科技公司，百望股份始終將真實交易數據作為AI時代的核心競爭力，過去十年累計處理發票超 260 億張，沉澱了覆蓋 9600萬餘個市場主體的海量高質量真實交易底賬數據，成為企業AI 能力建設的核心燃料！百望Tax-Swift護航中企全球化征程，全面印證場景落地能力作為百望股份全球化戰略的核心場景落地產品，Tax-Swift全球虛擬稅務平臺基於沉澱10年的監管科技與規則引擎能力，完成了全球化適配與升級，為中國企業的全球化征程搭建起全鏈路的合規屏障。具體而言，Tax-Swift以AI技術為核心驅動力，構建了覆蓋全球稅務合規全流程的閉環服務體系。平臺依托全球引擎基座、發票引擎、稅務規則引擎、國家適配器四層核心架構，可自動完成多語言轉換、實時匯率校准、多格式報文轉換、電子簽名校驗、智能算稅算法、合規風險過濾、稅收優惠適配等全流程操作，實現了企業ERP系統到全球各國稅務系統的無縫直連，可深度適配全球主流稅務監管體系。目前，平臺已覆蓋10餘種主流語言、200餘種票據格式標准、3萬餘條國際財稅規則，已在多個中企出海場景落地見效。例如，某中國餐飲集團出海越南時，接入Tax-Swift平臺後，順利完成了越南當地門店的稅務合規體系搭建，實現了規模化落地。今年初，百望再度升級推出Tax-Swift Bai-Claw（全球稅務數字員工平臺），可覆蓋全球50餘個國家和地區的財稅合規需求，AI數字員工全面掌握權威財稅政策、行業知識與專業技能，可根據企業需求定制化部署，成為中企出海隨身隨行的合規哨兵。百望股份CSO劉揚在演講中表示："政策、數據、AI與全球化正在形成新的共振。交易無國界，納稅有主權，全球數字貿易正在進入主權卡位與信用卡位的全新階段。百望股份期望以本次峰會為契機，持續深化技術創新與產業實踐，以數智能力築牢中國企業出海的合規屏障，以商業信用基礎設施賦能全球貿易的高質量發展，攜手各界夥伴共同賦能國家一帶一路戰略，為構建網絡空間命運共同體貢獻力量。"隨著AI技術的持續深化與全球化布局的穩步推進，百望股份正在以技術創新打破跨境貿易的合規壁壘，為中國企業出海鋪就一條安全、高效的數字化通路，在全球數字貿易的新賽道上，書寫中國科技企業的全新篇章。 Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
時隔31年，Jumanji將回歸該系列的根源
Tri Star/Kobal/Shutterstock(SeaPRwire) - 2024年4月7日，一集《週六夜現場》的短劇中，主持人克莉絲汀·薇格飾演一名對桌遊有奇怪恐懼的女性。具體來說，她害怕「被野蠻遊戲化」——也就是被吸進桌遊裡。但她的朋友（由安德魯·迪斯穆克斯飾演）對她的前提提出了異議。在《野蠻遊戲》中，只有一個人被吸進野蠻遊戲裡。劇情實際上是關於野蠻遊戲從遊戲中跑出來。派對上的另一個人則感到困惑，因為她以為《野蠻遊戲》是關於一群人被吸進電子遊戲裡。但有人好心地向她解釋，那是新版《野蠻遊戲》，不是原版。不過，她可能說對了，因為這個重啟系列的下一個篇章，終於將讓野蠻遊戲從遊戲中跑出來。《野蠻遊戲：開放世界》將電玩角色帶到現實世界。| Sony Pictures在CinemaCon上，Sony以宣布當前《野蠻遊戲》電影系列的第三部作品作為其發表會的壓軸，這部新作將原版1981年電影的桌遊更新為電子遊戲。巨石強森和凱文·哈特宣布這部新電影將命名為《野蠻遊戲：開放世界》。向現場觀眾展示的預告片描繪了我們的青少年主角（亞歷克斯·沃爾夫）意識到來自《野蠻遊戲》遊戲的角色化身實際上已被帶到現實世界。但這些角色並非由現實世界的玩家操控，而是卡在「試玩模式」，這意味著他們與我們之前看到的樣子不同；例如，巨石強森飾演的「布雷夫史東博士」說話就帶著西班牙口音。原版《野蠻遊戲》講述野生動物逃出遊戲，在小鎮上造成嚴重破壞。| Moviestore/Shutterstock哈特在發表會中指出，《野蠻遊戲》的「遊戲規則」在《開放世界》中並不總是適用，而且我們實際上會在電影中看到這些角色化身的三種不同版本。對粉絲中那些《野蠻遊戲》考據派來說不幸的是，故事並不會完全遵循野蠻遊戲跑出遊戲的設定，因為該系列的原版玩家將再次進入遊戲。但電影仍會向原版電影致敬，包括對原版明星羅賓·威廉斯的一段延伸致敬。無論這部電影有多少時間在探索外部世界，這對該系列來說仍然是一個好的轉變。《野蠻遊戲》的世界只能維持《一級玩家》式的冒險一段時間，久了就會變得重複，而原版電影最大的樂趣之一，就是看著獅子、犀牛和大獵人在我們的現代世界中橫行。將這個概念更新並在2026年上映，可能是《開放世界》最有趣的舉措之一，即使這會讓現實生活中的桌遊玩家更加困惑。《野蠻遊戲：開放世界》將於2026年12月25日在戲院首映。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈，覆蓋超過6,500個媒體庫、86,000名編輯和記者，以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。